Background: Melasma is an acquired, facial hyperpigmentation without a specific origin. It is regularly associated with multiple etiologic factors such as pregnancy, genetic, racial, and from estrogen administration. Among the methods to treat skin hyperpigmentation a series of skin bleaching agents have been used. At present, the most commonly used agent is known as hydroquinone. Nowadays, it is known that hydroquinone can cause cancer in animals with unknown relevance to humans.
| INTRODUC TI ON
Hydroquinone is an aromatic compound in the form of light tan to gray crystals. It is used as a skin bleaching agent, in cosmetics, hair dye, glue, and as medication to treat melasma. Hydroquinone is biodegradable but can be toxic to microorganisms at high concentrations.
1 People using commercial skin lighteners containing hydroquinone developed a blue-or brownish-blue-colored skin.
Effects on the kidney, liver, and forestomach, including cancer, were found in laboratory rats fed hydroquinone in the diet or in water. 
| MATERIAL S AND ME THODS

| Materials
Hydroquinone (C 6 H 6 O 2 , Figure 1 ) was purchased from Sigma Aldrich and used as received. The hydroquinone solution was prepared in a weight ratio of 10:1 of deionized water and ethanol respectively.
| Methods
The study involves 31 patients presenting melasma (27 females and 
| RE SULTS AND D ISCUSS I ON
The Raman spectroscopy measurements for hydroquinone are pre- The Raman spectra for the 18 patients taken before and after treatment, were preprocessed as mentioned in the above section including both the Raman spectra of patients responding to the treatment and patients not responding to the treatment. The normalized spectra before and after the treatment are shown in Figure 3 , were 
| CON CLUS ION
Nowadays in Mexico melasma is commonly treated under a triple combination bleaching agent (Tretinoin, Fluocinolone, and Hydroquinone), the latter with great interest because it is used as the gold standard method 10 to treat melasma and it has been observed that the abuse in the application of this type of topical treatments has developed visible alterations in the skin, such as blue or brownish-blue-colored skin. Hydroquinone has been confirmed to cause cancer in animals, although there is no scientific evidence of its carcinogenicity in humans. 1 The implementation of optical techniques to medical applications is of great interest because it is a non-invasive method, sample preparation is not necessary, and it is a high precision technique.
Raman spectroscopy is an efficient tool to obtain the molecular fingerprint of a sample, which in dermatological applications, could detect the presence of external substances contained in the skin. In previous work from our group 5 , we showed that melasma patient unresponsive to treatment had an abnormal melanin. In this work, Raman spectroscopy was found useful for non-invasive assessment of hydroquinone during the treatment of melasma, regardless of the patient's response to such treatment. Although our method in its current form has not been validated for routine clinical treatment or follow-up, it can be a useful tool in research on hydroquinone and skin pharmacology.
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